Metan, G. Et Al. 2012. What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?. Scandinavian Journal of Infectious Diseases , vol.44, no.5 , 330-336.

Metan, G., KOÇ, A. N., Atalay, A., Kaynar, L., ÖZTÜRK, A., Alp, E., ... ESER, B.(2012). What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?. Scandinavian Journal of Infectious Diseases , vol.44, no.5, 330-336.

Metan, Gökhan Et Al. "What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?," Scandinavian Journal of Infectious Diseases , vol.44, no.5, 330-336, 2012

Metan, Gökhan Et Al. "What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?." Scandinavian Journal of Infectious Diseases , vol.44, no.5, pp.330-336, 2012

Metan, G. Et Al. (2012) . "What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?." Scandinavian Journal of Infectious Diseases , vol.44, no.5, pp.330-336.

@article{article, author={Gökhan METAN Et Al. }, title={What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?}, journal={Scandinavian Journal of Infectious Diseases}, year=2012, pages={330-336} }